123 related articles for article (PubMed ID: 8957720)
21. Analysis of 553 episodes of monomicrobial bacteraemia in cancer patients: any association between risk factors and outcome to particular pathogen?
Spanik S; Kukuckova E; Pichna P; Grausova S; Krupova I; Rusnakova V; Kralovicova K; Krchnakova A; Mrazova M; Lacka J; Koren P; Stopkova K; Nogova J; Demitrovicova A; Helpianska L; Krcmery V
Support Care Cancer; 1997 Jul; 5(4):330-3. PubMed ID: 9257432
[TBL] [Abstract][Full Text] [Related]
22. Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case-controlled study.
Spanik S; Krupova I; Trupl J; Kunová A; Novotny J; Mateicka F; Pichnova E; Sulcova M; Sabo A; Jurga L; Krcmery V
J Infect Chemother; 1999 Sep; 5(3):180-184. PubMed ID: 11810513
[TBL] [Abstract][Full Text] [Related]
23. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients.
Shi SH; Kong HS; Xu J; Zhang WJ; Jia CK; Wang WL; Shen Y; Zhang M; Zheng SS
Transpl Infect Dis; 2009 Oct; 11(5):405-12. PubMed ID: 19638006
[TBL] [Abstract][Full Text] [Related]
24. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
[TBL] [Abstract][Full Text] [Related]
25. Microbiological data for patients with febrile neutropenia.
Kanamaru A; Tatsumi Y
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S7-S10. PubMed ID: 15250014
[TBL] [Abstract][Full Text] [Related]
26. Predictors of mortality in bacteremic cancer patients: retrospective analysis of 64 deaths occurring among 262 bacteremic episodes.
Spanik S; Sufliarsky J; Mardiak J; Sorkovska D; Trupl J; Kunova A; Kukuckova E; Rusnakova V; Demitrovicova A; Pichna P; Krupova I; Kralovicova K; Mateićka F; West D; Krcmery V
Support Care Cancer; 1998 May; 6(3):291-4. PubMed ID: 9629885
[TBL] [Abstract][Full Text] [Related]
27. Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented gram-positive activity on infectious morbidity. National Cancer Institute of Canada Clinical Trials Group.
Bow EJ; Mandell LA; Louie TJ; Feld R; Palmer M; Zee B; Pater J
Ann Intern Med; 1996 Aug; 125(3):183-90. PubMed ID: 8686975
[TBL] [Abstract][Full Text] [Related]
28. Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma.
Muñoz L; Martino R; Subirà M; Brunet S; Sureda A; Sierra J
Leuk Lymphoma; 1999 Aug; 34(5-6):585-9. PubMed ID: 10492083
[TBL] [Abstract][Full Text] [Related]
29. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
30. Bloodstream infections in a neonatal intensive-care unit: 12 years' experience with an antibiotic control program.
Cordero L; Sananes M; Ayers LW
Infect Control Hosp Epidemiol; 1999 Apr; 20(4):242-6. PubMed ID: 10219874
[TBL] [Abstract][Full Text] [Related]
31. Bacteremia due to Pseudomonas aeruginosa: results from a 3-year national study in the Slovak Republic.
Koprnova J; Beno P; Korcova J; Mrazova M; Grey E; Liskova A; Harnicarova A; Karvaj M; Koval S; Zak V; Danaj M; Streharova A; Mitterpachova E; Miklosko J; Ondrusova A; Riedl J; Kaiserova E; Prokopova V; Hornova M; Payer J; Rudinsky B; Pevalova L; Bencelova M; Hanzen J; Macekova L; Csölleyova J; Krcmery V
J Chemother; 2005 Oct; 17(5):470-6. PubMed ID: 16323434
[TBL] [Abstract][Full Text] [Related]
32. An analysis of hospital-acquired bacteraemia in intensive care unit patients in a university hospital in Kuwait.
Jamal WY; El-Din K; Rotimi VO; Chugh TD
J Hosp Infect; 1999 Sep; 43(1):49-56. PubMed ID: 10462639
[TBL] [Abstract][Full Text] [Related]
33. Polymicrobial bacteremia in cancer patients: analysis of risk factors, etiology and outcome in 214 episodes.
Ilavska I; Pichna P; Stopkova K; Grausova S; Krupova I; Oravcova E; Koren P; Lacka J; Studena M; Spanik S; Kunova A; Trupl J; Krcmery V
Int J Antimicrob Agents; 1996 Jul; 7(2):101-7. PubMed ID: 18611744
[TBL] [Abstract][Full Text] [Related]
34. [Bacteremias in a university hospital: study of etiologic agents and their sensitivity patterns].
Betriu C; Palau L; Gómez M; Sánchez A; Romero J; Picazo JJ
Rev Clin Esp; 1999 Aug; 199(8):503-10. PubMed ID: 10522430
[TBL] [Abstract][Full Text] [Related]
35. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.
Busca A; Cavecchia I; Locatelli F; D'Ardia S; De Rosa FG; Marmont F; Ciccone G; Baldi I; Serra R; Gaido E; Falda M
Transpl Infect Dis; 2012 Feb; 14(1):40-8. PubMed ID: 21599817
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of bloodstream infections at a cancer center.
Velasco E; Thuler LC; Martins CA; Nucci M; Dias LM; Gonçalves VM
Sao Paulo Med J; 2000 Sep; 118(5):131-8. PubMed ID: 11018846
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic use and development of resistance in blood culture isolates: 8 years of experience from a cancer referral center.
Krcméry V; Sykora P; Trupl J; Kunova A; Sabo A; Jurga L; Novotny J; Mateicka F; Babela R; Pichnova E; Gould IM
J Chemother; 2001 Apr; 13(2):133-42. PubMed ID: 11330359
[TBL] [Abstract][Full Text] [Related]
38. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].
Ugarte-Torres A; Villasis-Keever A; Hernández-Bribiesca ME; Crespo-Solis E; Ruiz-Palacios GM; Sifuentes-Osornio J; Ponce-De-León-Garduño A
Rev Invest Clin; 2006; 58(6):547-54. PubMed ID: 17432285
[TBL] [Abstract][Full Text] [Related]
39. Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures.
Frère P; Hermanne JP; Debouge MH; de Mol P; Fillet G; Beguin Y
Bone Marrow Transplant; 2004 Apr; 33(7):745-9. PubMed ID: 14743196
[TBL] [Abstract][Full Text] [Related]
40. Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms.
Rangaraj G; Granwehr BP; Jiang Y; Hachem R; Raad I
Cancer; 2010 Feb; 116(4):967-73. PubMed ID: 20052728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
